Discovery of [<sup>11</sup>C]MK-6884: A Positron Emission Tomography (PET) Imaging Agent for the Study of M4Muscarinic Receptor Positive Allosteric Modulators (PAMs) in Neurodegenerative DiseasesLing Tong, Robert Mazzola, Jenny Wai et al.|Journal of Medicinal Chemistry|2020Cited by 41
1029P Dazostinag (TAK-676) alone and in combination with pembrolizumab (pembro) in patients (pts) with advanced or metastatic solid tumors: Preliminary safety, PK/PD, and anti-tumor activity in a phase I dose escalation study supporting a recommended dose for expansion (RDE)Anthony J. Olszanski, Xīn Gào, Jason J. Luke et al.|Annals of Oncology|2023Cited by 14